Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Important Facts for Cancer Incidence - Mesothelioma

Definition

Mesothelioma incidence refers to the number of persons newly diagnosed with mesothelioma during a specified time period. Measures include 1) the number of newly diagnosed mesothelioma cases; and 2) age-adjusted mesothelioma incidence rates (adjusted to the 2000 US standard population). All rates are expressed per 100,000 persons. Measures are provided by sex and race/ethnicity.

Numerator

The number of mesothelioma cases newly diagnosed in New Mexico residents within a specified time period. The data are based on the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program incidence site recode for mesothelioma (SEER Recode B 36010); ICD-O-3 codes: histologies 9050-9055; Malignant cases: ICD behavior code 3.

Denominator

The estimated population of New Mexico residents within a specified time period.

Why Is This Important?

Mesothelioma is a relatively rare form of cancer that is primarily associated with long term exposure to asbestos. The majority of cases occur in males with a work history of prolonged exposure to asbestos. Mesothelioma can be difficult to diagnose, and most cases are not discovered until the cancer has spread throughout the body, making treatment difficult and the survival relatively low. Mesothelioma is relatively rare in the United States, and New Mexico averaged 17 new cases each year between 2010 and 2015. Because asbestos exposure is the predominant risk factor for developing mesothelioma, the vast majority of these cases are preventable by limiting exposure to asbestos.

Other Objectives

CDC Environmental Public Health Tracking, Nationally Consistent Data and Measures (EPHT NCDM)
The NM EPHT website is supported by Cooperative Agreement Number, 6 NUE1EH001354 (previously, 5 U38EH000949), funded by the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Sun, 20 October 2019 11:26:34 from New Mexico EPHT Tracking Public Web site: https://nmtracking.org/ ".

Content updated: Thu, 16 May 2019 10:54:01 MDT